SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-045722
Filing Date
2024-05-22
Accepted
2024-05-22 08:00:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0206352-424b3_cerotherap.htm 424B3 502020
2 GRAPHIC image_001.jpg GRAPHIC 3616
  Complete submission text file 0001213900-24-045722.txt   508325
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279156 | Film No.: 24971666
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)